川芎嗪合普米克治疗儿童哮喘30例临床观察  

Ligustrazine combine with Pulmicort on childhood asthma:an observation of 30 cases

作　　者：郭一兵[1] 陈金安[1] 

机构地区：[1]江苏省南通市第二人民医院,江苏南通226002

出　　处：《中医儿科杂志》2006年第5期30-31,共2页Journal of Pediatrics of Traditional Chinese Medicine

摘　　要：目的:观察川芎嗪联合普米克治疗儿童哮喘的临床疗效。方法:56例儿童哮喘随机分为治疗组(30例)和对照组(26例),治疗组采用川芎嗪静脉滴注、普米克雾化吸入治疗,对照组采用普米克雾化吸入治疗,观察两组患儿症状、体征恢复情况。结果:治疗组控制12例,显效9例,好转7例,无效2例,总显效率为70.00%;对照组控制5例,显效6例,好转12例,无效3例,总显效率为42.31%。两组有显著性差异(P<0.05)。结论:川芎嗪静脉滴注结合普米克雾化吸入能有效地治疗儿童哮喘。Objective：To observe the effect of Ligustrazine combine with Pulmicort on childhood asthma. Methods： 56 childhood asthma patients were randomly divided into two groups.30 cases were in treatment group and 26 in control group. The treatment group was treated with Ligustrazine intravenous drip and Pulmicort intake. The control group was treated with Pulmicort intake.The condition was observed through clinical symptom and sign in two groups. Results： In treatment group, 12 patients was under control, 9 marked effective, 7 turn for the better and 2 invalid. The total effect rate was 70.00 %. In contrast group, 5 Was under control, 6 marked effective, 12 turn for the better and 3 invalid. The total effect rate was 42.31%. The total effect rate of the two groups had significant difference. Conclusion： Ligustrazine intravenous drip combine with Pulmicort intake is effective in treating childhood asthma.

关 键 词：川芎嗪 普米克 哮喘 儿童 

分 类 号：R256.11[医药卫生—中医内科学]